Cas9 Protein Triggers Differential Expression of Inherent Genes Especially NGFR Expression in 293T Cells

Introduction CRISPR/CAS9 systems, which can be utilized in vitro biological experiments, have recently captured much attention for their important roles and benefits. However, full realization of the potential of CRISPR/CAS9 approaches requires addressing many challenges and side effects. The expression of genes and potential side effects of CRISPR/CAS9 in human cells remains to be elucidated. The aim of our study was to explore the effect of CRISPR/CAS9 on gene expression in 293T cells. Methods A Cas9-expressing PX458 plasmid and Cas9-deactivated PX458-T2A plasmid were used to study the role of CRISPR/CAS9 on regulating gene expression in 293T cells. Gene expression in 293T cells after transfection of the PX458 plasmid or PX458-T2A plasmid was detected by RNA sequencing and correlative statistical analysis. Differential gene expression in both PX458 transfected 293T cells and PX458-T2A transfected 293T cells compared with normal 293T cells was detected using quantitative reverse transcription polymerase chain reaction (RT qPCR). The mRNA and protein levels were measured using reverse transcription PCR and Western blot. Co-IP assay combined with shotgun LC-MS/MS were used to investigate the differences of NGFR-interaction proteins between PX458 transfected 293T cells and PX458-T2A transfected 293T cells. Results In this study, we observed that PX458 plasmid transfection and Cas9 expression can affect the expression of different genes, including FOSB (FBJ murine osteosarcoma viral oncogene homolog B), IL-11 (Interleukin-11), MMP1 (matrix metalloproteinase), CYP2D6 (CytochromeP4502D6), and NGFR (matrix metalloproteinase 1). Downregulation of NGFR after PX458 transfection was confirmed by RT qPCR and western blot analysis. NGFR expression was significantly lower in PX458 transfected 293T cells than in normal 293T cells and PX458-T2A transfected 293T cells. The co-IP dilutions analyzed by shotgun LC-MS/MS showed a total of 183 proteins interact with NGFR in PX458 transfected 293T cells while 221 proteins interact with NGFR were identified in PX458-T2A transfected 293T cells using the MASCOT engine. Conclusions Cas9 expression by transfection of the PX458 plasmid was negatively correlated with the NGFR mRNA level and NGFR protein expression in 293T cells, while PX458-T2A, in which Cas9 is deactivated, did not affect NGFR expression. The decrease in NGFR expression also affects the amount of proteins that interact with NGFR. These results suggest that the effect of Cas9 on NGFR expression and the expression of other genes should be noticed when developing cell-based studies and therapies utilizing CRISPR/CAS9 systems.

[1]  N. Bresolin,et al.  The low-affinity receptor for neurotrophins p75NTR plays a key role for satellite cell function in muscle repair acting via RhoA. , 2009, Molecular biology of the cell.

[2]  Colin N. Dewey,et al.  RSEM: accurate transcript quantification from RNA-Seq data with or without a reference genome , 2011, BMC Bioinformatics.

[3]  L. Schouls,et al.  Identification of genes that are associated with DNA repeats in prokaryotes , 2002, Molecular microbiology.

[4]  N. Patron,et al.  Multi-gene engineering in plants with RNA-guided Cas9 nuclease. , 2016, Current opinion in biotechnology.

[5]  Yuriko Osakabe,et al.  Genome editing with engineered nucleases in plants. , 2015, Plant & cell physiology.

[6]  Neville E. Sanjana,et al.  Genome-Scale CRISPR-Cas9 Knockout Screening in Human Cells , 2014, Science.

[7]  Benjamin D. Sachs,et al.  p75 neurotrophin receptor regulates glucose homeostasis and insulin sensitivity , 2012, Proceedings of the National Academy of Sciences.

[8]  Duxin Sun,et al.  The eradication of breast cancer cells and stem cells by 8-hydroxyquinoline-loaded hyaluronan modified mesoporous silica nanoparticle-supported lipid bilayers containing docetaxel. , 2013, Biomaterials.

[9]  Mark D. Robinson,et al.  edgeR: a Bioconductor package for differential expression analysis of digital gene expression data , 2009, Bioinform..

[10]  G. Otting,et al.  NMR structure of the death domain of the p75 neurotrophin receptor , 1997, The EMBO journal.

[11]  Björn Usadel,et al.  Trimmomatic: a flexible trimmer for Illumina sequence data , 2014, Bioinform..

[12]  R. Barrangou,et al.  CRISPR/Cas, the Immune System of Bacteria and Archaea , 2010, Science.

[13]  Martin J. Aryee,et al.  Transcriptome-wide off-target RNA editing induced by CRISPR-guided DNA base editors , 2019, Nature.

[14]  Dana Carroll,et al.  Origins of Programmable Nucleases for Genome Engineering. , 2016, Journal of molecular biology.

[15]  J. Keith Joung,et al.  Improving CRISPR-Cas nuclease specificity using truncated guide RNAs , 2014, Nature Biotechnology.

[16]  Benjamin L. Oakes,et al.  CRISPR-CasX is an RNA-dominated enzyme active for human genome editing , 2019, Nature.

[17]  Shoana L. Sikorski,et al.  Regulation of Hepatic Stellate Cell Differentiation by the Neurotrophin Receptor p75NTR , 2007, Science.

[18]  Thomas R. Gingeras,et al.  STAR: ultrafast universal RNA-seq aligner , 2013, Bioinform..

[19]  Zhiyao He,et al.  CRISPR/Cas9-Mediated Genome Editing of Epigenetic Factors for Cancer Therapy. , 2015, Human gene therapy.

[20]  E. Lander,et al.  Genetic Screens in Human Cells Using the CRISPR-Cas9 System , 2013, Science.

[21]  J. Chamberlain,et al.  Cas9 immunity creates challenges for CRISPR gene editing therapies , 2018, Nature Communications.

[22]  Rudolf Jaenisch,et al.  One-Step Generation of Mice Carrying Mutations in Multiple Genes by CRISPR/Cas-Mediated Genome Engineering , 2013, Cell.

[23]  George Church,et al.  Next stop for the CRISPR revolution: RNA‐guided epigenetic regulators , 2016, The FEBS journal.

[24]  K. Makino,et al.  Nucleotide sequence of the iap gene, responsible for alkaline phosphatase isozyme conversion in Escherichia coli, and identification of the gene product , 1987, Journal of bacteriology.

[25]  R. Jaenisch,et al.  One-Step Generation of Mice Carrying Reporter and Conditional Alleles by CRISPR/Cas-Mediated Genome Engineering , 2013, Cell.

[26]  Feng Zhang,et al.  CRISPR-assisted editing of bacterial genomes , 2013, Nature Biotechnology.

[27]  T. Roskams,et al.  Human and rat hepatic stellate cells express neurotrophins and neurotrophin receptors , 2001, Hepatology.

[28]  Alexandro E. Trevino,et al.  Genome-scale transcriptional activation by an engineered CRISPR-Cas9 complex , 2014, Nature.

[29]  David A. Scott,et al.  Genome engineering using the CRISPR-Cas9 system , 2013, Nature Protocols.

[30]  B. Oh,et al.  Crystal structure of the Csm1 subunit of the Csm complex and its single-stranded DNA-specific nuclease activity. , 2015, Structure.

[31]  Xingliang Ma,et al.  CRISPR/Cas9-Based Genome Editing in Plants. , 2017, Progress in molecular biology and translational science.

[32]  Shiyou Zhu,et al.  High-throughput screening of a CRISPR/Cas9 library for functional genomics in human cells , 2014, Nature.

[33]  JoungJ. Keith,et al.  Dimeric CRISPR RNA-Guided FokI-dCas9 Nucleases Directed by Truncated gRNAs for Highly Specific Genome Editing , 2015 .

[34]  Benjamin L. Oakes,et al.  CRISPR-CasX is an RNA-dominated enzyme active for human genome editing , 2019, Nature.

[35]  R. Ramirez-Solis,et al.  Genome editing: A perspective on the application of CRISPR/Cas9 to study human diseases (Review) , 2019, International journal of molecular medicine.

[36]  B. Liu,et al.  CRISPR/Cas9: a powerful tool for identification of new targets for cancer treatment. , 2019, Drug discovery today.

[37]  Dandan Zhang,et al.  Targeted Gene Manipulation in Plants Using the CRISPR/Cas Technology. , 2016, Journal of genetics and genomics = Yi chuan xue bao.

[38]  Max A. Horlbeck,et al.  Genome-Scale CRISPR-Mediated Control of Gene Repression and Activation , 2014, Cell.

[39]  Eli J. Fine,et al.  DNA targeting specificity of RNA-guided Cas9 nucleases , 2013, Nature Biotechnology.

[40]  Zigang Dong,et al.  CRISPR/Cas9 – An evolving biological tool kit for cancer biology and oncology , 2019, npj Precision Oncology.

[41]  J. Jenkins,et al.  NGF gene expression and secretion in white adipose tissue: regulation in 3T3-L1 adipocytes by hormones and inflammatory cytokines. , 2004, American journal of physiology. Endocrinology and metabolism.

[42]  Jay Shendure,et al.  Saturation Editing of Genomic Regions by Multiplex Homology-Directed Repair , 2014, Nature.

[43]  D. Guo,et al.  Application of CRISPR/Cas9-Based Gene Editing in HIV-1/AIDS Therapy , 2019, Front. Cell. Infect. Microbiol..

[44]  Eugene V Koonin,et al.  Unification of Cas protein families and a simple scenario for the origin and evolution of CRISPR-Cas systems , 2011, Biology Direct.